SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Noven Pharmaceuticals Inc. Completes Phase 3 Clinical Program for Investigational Non-Hormonal Therapy for Menopausal Vasomotor Symptoms